Researchers have found that lipid biomarkers can be used to predict a small amount of variance in cognition, by using blood samples from the Lothian 1936 birth cohort. Finding effective biomarkers – biological signs – of cognitive ability is critical to our understanding of the early stage disease processes, where there is most chance of developing effective interventions. This was a DPUK-funded study, led by Professor Ian Deary at the University of Edinburgh.
DPUK enabled experimental medicine Impact Stem cells
The Deep and Frequent Phenotyping (DFP) study will be almost certainly the most extensively assessed cohort of people with very early Alzheimer’s disease and mild cognitive impairment. This is a DPUK-funded study led by Professor Richard Wade-Martins at the University of Oxford.